• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Wnt5a诱导ROR1与HS1形成复合物,以增强慢性淋巴细胞白血病细胞的迁移。

Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.

作者信息

Hasan M K, Yu J, Chen L, Cui Bing, Widhopf Ii G F, Rassenti L, Shen Z, Briggs S P, Kipps T J

机构信息

Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.

Section of Cell and Developmental Biology, University of California San Diego, La Jolla, CA, USA.

出版信息

Leukemia. 2017 Dec;31(12):2615-2622. doi: 10.1038/leu.2017.133. Epub 2017 May 3.

DOI:10.1038/leu.2017.133
PMID:28465529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5670028/
Abstract

ROR1 (receptor tyrosine kinase-like orphan receptor 1) is a conserved, oncoembryonic surface antigen expressed in chronic lymphocytic leukemia (CLL). We found that ROR1 associates with hematopoietic-lineage-cell-specific protein 1 (HS1) in freshly isolated CLL cells or in CLL cells cultured with exogenous Wnt5a. Wnt5a also induced HS1 tyrosine phosphorylation, recruitment of ARHGEF1, activation of RhoA and enhanced chemokine-directed migration; such effects could be inhibited by cirmtuzumab, a humanized anti-ROR1 mAb. We generated truncated forms of ROR1 and found its extracellular cysteine-rich domain or kringle domain was necessary for Wnt5a-induced HS1 phosphorylation. Moreover, the cytoplamic, and more specifically the proline-rich domain (PRD), of ROR1 was required for it to associate with HS1 and allow for F-actin polymerization in response to Wnt5a. Accordingly, we introduced single amino acid substitutions of proline (P) to alanine (A) in the ROR1 PRD at positions 784, 808, 826, 841 or 850 in potential SH3-binding motifs. In contrast to wild-type ROR1, or other ROR1 mutants, ROR1 had impaired capacity to recruit HS1 and ARHGEF1 to ROR1 in response to Wnt5a. Moreover, Wnt5a could not induce cells expressing ROR1 to phosphorylate HS1 or activate ARHGEF1, and was unable to enhance CLL-cell motility. Collectively, these studies indicate HS1 plays an important role in ROR1-dependent Wnt5a-enhanced chemokine-directed leukemia-cell migration.

摘要

ROR1(受体酪氨酸激酶样孤儿受体1)是一种保守的癌胚表面抗原,在慢性淋巴细胞白血病(CLL)中表达。我们发现,在新鲜分离的CLL细胞或用外源性Wnt5a培养的CLL细胞中,ROR1与造血谱系细胞特异性蛋白1(HS1)相关联。Wnt5a还诱导HS1酪氨酸磷酸化、ARHGEF1的募集、RhoA的激活并增强趋化因子导向的迁移;这些效应可被人源化抗ROR1单克隆抗体cirmtuzumab抑制。我们构建了ROR1的截短形式,发现其富含半胱氨酸的胞外结构域或kringle结构域对于Wnt5a诱导的HS1磷酸化是必需的。此外,ROR1的胞质结构域,更具体地说是富含脯氨酸的结构域(PRD),是其与HS1结合并允许响应Wnt5a发生F-肌动蛋白聚合所必需的。因此,我们在ROR1 PRD中潜在的SH3结合基序的第784、808、826、841或850位将脯氨酸(P)替换为丙氨酸(A)进行单氨基酸替换。与野生型ROR1或其他ROR1突变体相比,ROR1响应Wnt5a将HS1和ARHGEF1募集到ROR1的能力受损。此外,Wnt5a不能诱导表达ROR1的细胞使HS1磷酸化或激活ARHGEF1,并且无法增强CLL细胞的运动性。总的来说,这些研究表明HS1在ROR1依赖的Wnt5a增强趋化因子导向的白血病细胞迁移中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/ef61087d9f50/leu2017133f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/cbf4386d1bfd/leu2017133f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/599f038da64b/leu2017133f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/c6e95045c4ad/leu2017133f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/9fe3d1cf8c21/leu2017133f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/64d9138dfa04/leu2017133f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/ef61087d9f50/leu2017133f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/cbf4386d1bfd/leu2017133f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/599f038da64b/leu2017133f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/c6e95045c4ad/leu2017133f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/9fe3d1cf8c21/leu2017133f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/64d9138dfa04/leu2017133f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c5/5729332/ef61087d9f50/leu2017133f6.jpg

相似文献

1
Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.Wnt5a诱导ROR1与HS1形成复合物,以增强慢性淋巴细胞白血病细胞的迁移。
Leukemia. 2017 Dec;31(12):2615-2622. doi: 10.1038/leu.2017.133. Epub 2017 May 3.
2
Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells.Wnt5a 导致 ROR1 形成复合物并激活 cortactin,从而增强慢性淋巴细胞白血病细胞的迁移。
Leukemia. 2019 Mar;33(3):653-661. doi: 10.1038/s41375-018-0306-7. Epub 2018 Dec 19.
3
Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia.Wnt5a 诱导 ROR1 招募 DOCK2 以激活慢性淋巴细胞白血病中的 Rac1/2。
Blood. 2018 Jul 12;132(2):170-178. doi: 10.1182/blood-2017-12-819383. Epub 2018 Apr 20.
4
Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells.Wnt5a诱导ROR1与14-3-3ζ结合,以增强慢性淋巴细胞白血病细胞的趋化性和增殖能力。
Leukemia. 2017 Dec;31(12):2608-2614. doi: 10.1038/leu.2017.132. Epub 2017 May 3.
5
Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism.Wnt5a 通过 ROR1/DOCK2 依赖的机制增强慢性淋巴细胞白血病的增殖和 ERK1/2 磷酸化。
Leukemia. 2021 Jun;35(6):1621-1630. doi: 10.1038/s41375-020-01055-7. Epub 2020 Oct 23.
6
Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.Wnt5a诱导ROR1/ROR2异源寡聚化以增强白血病的趋化性和增殖。
J Clin Invest. 2016 Feb;126(2):585-98. doi: 10.1172/JCI83535.
7
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia.I 期临床试验:西仑吉肽抑制慢性淋巴细胞白血病患者的 ROR1 信号和干性特征。
Cell Stem Cell. 2018 Jun 1;22(6):951-959.e3. doi: 10.1016/j.stem.2018.05.018.
8
Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia.西姆土珠单抗通过阻断 Wnt5a/ROR1 对 NF-κB 的刺激,抑制慢性淋巴细胞白血病中的自分泌 STAT3 激活。
Blood. 2019 Sep 26;134(13):1084-1094. doi: 10.1182/blood.2019001366. Epub 2019 Aug 13.
9
Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib.在接受依鲁替尼治疗的慢性淋巴细胞白血病中,西妥昔单抗抑制Wnt5a诱导的Rac1激活。
Leukemia. 2017 Jun;31(6):1333-1339. doi: 10.1038/leu.2016.368. Epub 2016 Dec 1.
10
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.Wnt-5a的自分泌信号传导失调白血病细胞的趋化作用并预测慢性淋巴细胞白血病的临床结果。
Clin Cancer Res. 2016 Jan 15;22(2):459-69. doi: 10.1158/1078-0432.CCR-15-0154. Epub 2015 Aug 3.

引用本文的文献

1
Wnt5a induces ROR1 dependent NF-κB activation to enhance MMP-9 expression and invasiveness in chronic lymphocytic leukemia.Wnt5a通过诱导ROR1依赖的NF-κB激活来增强慢性淋巴细胞白血病中基质金属蛋白酶-9(MMP-9)的表达及侵袭性。
Leukemia. 2025 Apr 28. doi: 10.1038/s41375-025-02616-4.
2
Therapeutic advances in the targeting of ROR1 in hematological cancers.血液系统恶性肿瘤中靶向ROR1的治疗进展。
Cell Death Discov. 2024 Nov 17;10(1):471. doi: 10.1038/s41420-024-02239-1.
3
Receptor tyrosine kinase-like orphan receptor 1: A novel antitumor target in gastrointestinal cancers.

本文引用的文献

1
Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib.在接受依鲁替尼治疗的慢性淋巴细胞白血病中,西妥昔单抗抑制Wnt5a诱导的Rac1激活。
Leukemia. 2017 Jun;31(6):1333-1339. doi: 10.1038/leu.2016.368. Epub 2016 Dec 1.
2
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia.高水平的ROR1与慢性淋巴细胞白血病的疾病进展加速相关。
Blood. 2016 Dec 22;128(25):2931-2940. doi: 10.1182/blood-2016-04-712562. Epub 2016 Nov 4.
3
Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
受体酪氨酸激酶样孤儿受体1:胃肠道癌症中的一种新型抗肿瘤靶点。
World J Clin Oncol. 2024 May 24;15(5):603-613. doi: 10.5306/wjco.v15.i5.603.
4
Role of the Ror family receptors in Wnt5a signaling.Ror 家族受体在 Wnt5a 信号通路中的作用。
In Vitro Cell Dev Biol Anim. 2024 May;60(5):489-501. doi: 10.1007/s11626-024-00885-4. Epub 2024 Apr 8.
5
Identification of the Axis β-Catenin-BTK in the Dynamic Adhesion of Chronic Lymphocytic Leukemia Cells to Their Microenvironment.鉴定慢性淋巴细胞白血病细胞与其微环境动态黏附中的轴 β-连环蛋白-BTK。
Int J Mol Sci. 2023 Dec 18;24(24):17623. doi: 10.3390/ijms242417623.
6
Celsr1 suppresses Wnt5a-mediated chemoattraction to prevent incorrect rostral migration of facial branchiomotor neurons.Celsr1 抑制 Wnt5a 介导的趋化作用,以防止面部分支运动神经元的不正确的头侧迁移。
Development. 2022 Nov 15;149(22). doi: 10.1242/dev.200553. Epub 2022 Nov 16.
7
Ror1 is expressed inducibly by Notch and hypoxia signaling and regulates stem cell-like property of glioblastoma cells.Ror1 通过 Notch 和缺氧信号诱导表达,并调节神经胶质瘤细胞的干细胞样特性。
Cancer Sci. 2023 Feb;114(2):561-573. doi: 10.1111/cas.15630. Epub 2022 Nov 25.
8
Hematopoietic stem cell regeneration through paracrine regulation of the Wnt5a/Prox1 signaling axis.通过旁分泌调节 Wnt5a/Prox1 信号轴实现造血干细胞再生。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI155914.
9
ROR1: an orphan becomes apparent.ROR1:一个孤儿变得明显。
Blood. 2022 Oct 6;140(14):1583-1591. doi: 10.1182/blood.2021014760.
10
New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.从 ROR1 相互作用组的蛋白质组学和药理学调节中获得关于 ROR1、ROR2 和 PTK7 信号转导的分子机制的新见解。
Cell Mol Life Sci. 2022 May 4;79(5):276. doi: 10.1007/s00018-022-04301-6.
慢性淋巴细胞白血病中IgM和IgD信号传导的功能差异
J Immunol. 2016 Sep 15;197(6):2522-31. doi: 10.4049/jimmunol.1600915. Epub 2016 Aug 17.
4
Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation.Wnt5a-Ror1/Ror2信号通路在后肾间充质和输尿管芽形成中的重要作用。
Genes Cells. 2016 Apr;21(4):325-34. doi: 10.1111/gtc.12342. Epub 2016 Feb 3.
5
Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.Wnt5a诱导ROR1/ROR2异源寡聚化以增强白血病的趋化性和增殖。
J Clin Invest. 2016 Feb;126(2):585-98. doi: 10.1172/JCI83535.
6
Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1.UC-961(一种靶向ROR1的首创单克隆抗体)的临床前特异性和安全性
Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl(0):S167-9. doi: 10.1016/j.clml.2015.02.010.
7
Role of cortactin homolog HS1 in transendothelial migration of natural killer cells.皮层肌动蛋白同源物HS1在自然杀伤细胞跨内皮迁移中的作用。
PLoS One. 2015 Feb 27;10(2):e0118153. doi: 10.1371/journal.pone.0118153. eCollection 2015.
8
SDF1α-induced interaction of the adapter proteins Nck and HS1 facilitates actin polymerization and migration in T cells.基质细胞衍生因子1α(SDF1α)诱导衔接蛋白Nck和HS1相互作用,促进T细胞中的肌动蛋白聚合和迁移。
Eur J Immunol. 2015 Feb;45(2):551-61. doi: 10.1002/eji.201444473. Epub 2014 Nov 28.
9
ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice.ROR1 可与 TCL1 相互作用,并增强 Eμ-TCL1 转基因小鼠的白血病发生。
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):793-8. doi: 10.1073/pnas.1308374111. Epub 2013 Dec 30.
10
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.靶向慢性淋巴细胞白血病中的 LYN/HS1 信号轴。
Blood. 2013 Mar 21;121(12):2264-73. doi: 10.1182/blood-2012-09-457119. Epub 2013 Jan 16.